Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jen Smrtka

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
Multiple Sclerosis and Related Disorders|August 9, 2024
Shared decision-making in underserved populations with multiple sclerosis: A systematic reviewAliza Bitton Ben-Zacharia, Jen Smrtka, J Tamar Kalina, et al.
Frontiers in Immunology|December 5, 2025
Natalizumab and fumarate treatment differentially modulate CD4+ T cell and B cell subtypes in multiple sclerosis patients without impacting durable COVID-19 vaccine responsesRyan Curtin, Yogambigai Velmurugu, Fatoumatta Dibba, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
Multiple Sclerosis and Related Disorders|August 9, 2024
Shared decision-making in underserved populations with multiple sclerosis: A systematic reviewAliza Bitton Ben-Zacharia, Jen Smrtka, J Tamar Kalina, et al.
Frontiers in Immunology|December 5, 2025
Natalizumab and fumarate treatment differentially modulate CD4+ T cell and B cell subtypes in multiple sclerosis patients without impacting durable COVID-19 vaccine responsesRyan Curtin, Yogambigai Velmurugu, Fatoumatta Dibba, et al.
Pageof 1